“…We observed that compared with the non-PSD group, PSD group showed a higher proportion of female (40.80% vs. 20.37%, p = 0.024), lower years of education (9 [6-12] vs. 12 [9][10][11][12][13][14][15][16]; p = 0.044), higher stroke severity (NIHSS score: 5 [1.5-8.5] vs. 2 [1-4.5]; p = 0.046), worse cognitive function (MMSE score: 24 [22][23][24][25][26][27] vs. 27 [23-29]; p = 0.027) and lower monocyte count (0.50 [0.35-0.60] vs. 0.50 [0.48-0.70]; p = 0.007). BMI, pulmonary infection, medicines (antibiotic, statin and antiplatelet agents), vascular risk factors (hypertension, diabetes mellitus, heart disease, hyperlipidemia, smoking, drinking and previous stroke), stroke type including TOAST classification, stroke hemisphere, stroke location, the times from stroke onset to chest CT scan and to the blood sample collection, complete blood count parameters (leukocyte, neutrophil, lymphocyte and platelet counts, platelet-tolymphocyte ratio, neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio), and SV did not show any significantly association with PSD status.…”